Affinity of dihydropyrimidone analogues for adenosine A1 and A2A receptors / Runako Masline Katsidzira

Affinity of dihydropyrimidone analogues for adenosine A1 and A2A receptors / Runako Masline Katsidzira

Show other versions (1)

Parkinson’s disease (PD) is a neurodegenerative disorder that is characterised by a reduction of dopamine concentration in the striatum due to degeneration of dopaminergic neurons in the substantia nigra. Currently, first line treatment of PD includes the use of dopamine precursors, dopamine agonist...

Full description

Bibliographic Details
Main Author: Katsidzira, Runako Masline
Language:en
Published: 2014
Subjects:
Parkinson’s disease (PD)
3,4-dihydropyrimidin-2(1H)-ones
2-amino-1,4-dihydropyrimidines
Adenosine A1 antagonist
Adenosine A2A antagonist
Monoamine oxidase B
Parkinson se siekte
3,4-dihidropirimidien-2(1H)-one
2-amino-1,4-dihidropirimidiene
Adenosien A1-antagonis
Adenosien A2A-antagonis
Monoamienoksidase B
Online Access:http://hdl.handle.net/10394/10747

Internet

http://hdl.handle.net/10394/10747

Similar Items